title: [Knowledge, attitudes and practices of general practitioners about asthma in the city of Ouagadougou].
abstract: BACKGROUND
  In spite of a better understanding of the physiopathology of asthma and the existence of effective molecules, morbidity and mortality of asthma across the world are constantly increasing. International guidelines are not apparently applied. This study intended to assess the knowledge, attitudes and practices of general practitioners on asthma in Ouagadougou.
  
  
  METHODS
  This was a cross-sectional anonymous self-administered questionnaire involving 93 General Practitioners practicing in Ouagadougou.
  
  
  RESULTS
  The participation rate was 63.4% or 59 respondents. The majority of General Practitioners (88%).know the chronic nature of asthma and 61% of them had good knowledge of severe asthma signs. The post-exercise asthma and medication asthma were known respectively by 22% and 15% of General Practitioners. Knowledge of the technique of using pressurized metered dose inhalers was bad in 54% of General Practitioners. In intermittent asthma, 52.5% of General Practitioners prescribed steroids including 27% in oral form. Inhaled corticosteroids were associated with β2-agonists by 34% of General Practitioners in persistent asthma. After initial treatment, 44% of study physicians routinely referred their patients to pulmonologists. Drug costs, lack of in-service training and lack of national guidelines were perceived as barriers by 56%, 66% and 44% of General Practitioners.
  
  
  CONCLUSIONS
  The management of asthma is not optimal. The training of General Practitioners on the management of asthma is essential.
authors.affiliation: Service de Pneumologie, CHU Yalgado Ouedraogo, Ouagadougou , Burkina Faso. gisebad@yahoo.fr
authors.forename: G
authors.initials: G
authors.lastname: Badoum
authors.forename: S M
authors.initials: SM
authors.lastname: Ouédraogo
authors.forename: H
authors.initials: H
authors.lastname: Lankoande
authors.forename: G
authors.initials: G
authors.lastname: Ouédraogo
authors.forename: K
authors.initials: K
authors.lastname: Boncoungou
authors.forename: M
authors.initials: M
authors.lastname: Bambara
authors.forename: M
authors.initials: M
authors.lastname: Ouédraogo
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology*; D002050:Burkina Faso / Q000453:epidemiology; D003430:Cross-Sectional Studies; D019468:Disease Management; D005260:Female; D058005:General Practitioners / Q000523:psychology*; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology / Q000517:prevention & control; D012017:Referral and Consultation / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014504:Urban Health
chemical_list: D018927:Anti-Asthmatic Agents